Erin Borchardt

Title: **Innovative Mind: The Journey of Erin Borchardt**

Introduction

Erin Borchardt, an accomplished inventor based in Carrboro, NC, has made significant contributions to the field of genetic engineering and molecular biology. With a remarkable portfolio of two patents, Erin stands out as a pioneer in the development of innovative solutions that utilize circular RNA and advanced CRISPR technology.

Latest Patents

Erin's most recent patents highlight her commitment to advancing genetic research. The first patent, "Methods and Compositions for Circular RNA Molecules," focuses on AAV compositions for circular RNA expression. This invention provides methods for expressing covalently closed, circular RNA, which can have profound implications in gene therapy and molecular diagnostics. Erin's second patent, "Activatable CRISPR/Cas9 for Spatial and Temporal Control of Genome Editing," introduces a genetically encoded light- or chemically-activated Cas9. This innovation is engineered through the site-specific installation of an activatable lysine amino acid, enabling precise control over gene expression in a temporal and spatial manner, thus paving the way for advancements in gene editing methodologies.

Career Highlights

Erin has had an illustrious career, contributing her expertise in renowned institutions such as the University of North Carolina at Chapel Hill and the University of Pittsburgh. Her academic and professional background has provided her with a solid foundation to spearhead innovative projects that resonate within the scientific community.

Collaborations

Throughout her career, Erin has collaborated with esteemed colleagues, including Aravind Asokan and Alexander Deiters. These partnerships have fostered a rich exchange of ideas and have been crucial in the development and successful implementation of her patented technologies.

Conclusion

Erin Borchardt represents a new wave of innovators whose work is instrumental in the realms of genetic research and technological advancement. With her groundbreaking patents and professional collaborations, Erin continues to inspire and lead in the innovative landscape of biotechnology. The impact of her contributions has the potential to significantly influence future developments in therapeutic applications and genetic engineering.